Crescent Star Insurance Limited (PSX:CSIL)

CTI BioPharma Cash Flow Statement

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	3.23	45.81	56.92	4.51	38.79	48.91
Depreciation & Amortization	4.64	5.17	6.7	10.7	13.43	13.1
Other Amortization	0.02	0.02	0.08	0.17	0.22	0.13
Gain (Loss) on Sale of Assets	-1.71	-1.71	0	-	-1.14	-
Gain (Loss) on Sale of Investments	2.71	2.71	-1.11	-0	-	-
Change in Other Net Operating Assets	-38.44	-69.95	127.61	-43.66	-41.03	-56.26
Other Operating Activities	-35.33	-45.42	-56.92	-25.51	-7.91	4.4
Operating Cash Flow	-23.41	-21.9	143.81	-9.04	2.37	10.27
Operating Cash Flow Growth	-	-	-	-	-76.91%	-
Capital Expenditures	-10.13	-10.15	-0.65	-0.05	-0.03	0.85
Sale of Property, Plant & Equipment	2.08	2.08	0.04	-	2.7	-
Investment in Securities	23.51	22.29	-99.69	-8.22	-3.28	-74.01
Other Investing Activities	24.55	29.97	20.04	9.07	4.72	2.1
Investing Cash Flow	39.99	44.18	-80.26	0.8	4.11	-71.07
Total Debt Repaid	-	-	-	-	-2.59	-2.42
Net Debt Issued (Repaid)	-	-	-	-	-2.59	-2.42
Other Financing Activities	-	-	-64.72	-	-0.09	-0.58
Financing Cash Flow	-	-	-64.72	-	-2.68	-3
Miscellaneous Cash Flow Adjustments	0	0	-	-	-	-
Net Cash Flow	16.58	22.28	-1.17	-8.24	3.8	-63.79
Free Cash Flow	-33.55	-32.06	143.16	-9.09	2.35	11.12
Free Cash Flow Growth	-	-	-	-	-78.92%	-
Free Cash Flow Margin	-14.47%	-11.76%	47.52%	-4.71%	1.57%	6.83%
Free Cash Flow Per Share	-0.31	-0.30	1.33	-0.08	0.02	0.10
Cash Interest Paid	-	-	-	-	0.09	0.58
Cash Income Tax Paid	8.19	8.33	4.93	4.06	1.89	0.45
Levered Free Cash Flow	-41.82	-47.99	127.15	15.96	-4.78	69.08
Unlevered Free Cash Flow	-41.82	-47.99	127.15	15.96	-4.72	69.45
Change in Net Working Capital	39.88	70.25	-105.55	12.8	43.4	-19.85

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.